
Owners, management and financials
CVR: 44450569
Previous names: Novo Nordisk Foundation Cellerator P/S
DKK 3,903,000
Gross profit
Net result: DKK -13,054,000
NOVO NORDISK FONDEN (100%)
CVR · view owners
Thomas Hassing Ronøe Carlsen
Board: Mads Krogsgaard Thomsen (chair) and 2 members
CVR · view management
Active
Founded 23 November 2023
CVR · view overview
36 employees
CVR · 2026
Name registered: Novo Nordisk Foundation Cellerator A/S
CVR · 30/09/2026
View the full event history
Novo Nordisk Foundation Cellerator A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Novo Nordisk Foundation Cellerator P/S. The management consists of Thomas Hassing Ronøe Carlsen. The board consists of Mads Krogsgaard Thomsen (chair), Pelle Kristoffer Munk-Poulsen and Trine Haastrup. The company is owned by NOVO NORDISK FONDEN. The company has 36 employees (2026). In 2025, the company reported a gross profit of DKK 3,903,000 and a net result of DKK -13,054,000. Equity in the 2025 report amounted to DKK 346,460,000.
Selskabets formål er at drive virksomhed inden for udvikling af celleterapi til forskning og klinisk brug samt at drive anden i forbindelse hermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 3.9M | -13.1M | 392.3M | 346.5M | 15 |
Compared to 1.034 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Novo Nordisk Foundation Cellerator A/S is 44450569.
Novo Nordisk Foundation Cellerator A/S is owned by NOVO NORDISK FONDEN.
The management of Novo Nordisk Foundation Cellerator A/S consists of Thomas Hassing Ronøe Carlsen.
The board of Novo Nordisk Foundation Cellerator A/S consists of Mads Krogsgaard Thomsen, Pelle Kristoffer Munk-Poulsen and Trine Haastrup, with Mads Krogsgaard Thomsen as chair.
In 2025, Novo Nordisk Foundation Cellerator A/S reported a gross profit of DKK 3,903,000.
Novo Nordisk Foundation Cellerator A/S had 36 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new email: [email protected], new website: www.cellerator.dk (October 14, 2026).
Contact info changed: new email: [email protected], new website: www.cellerator.dk (October 1, 2026).
On September 30, 2026, the company changed its name from Novo Nordisk Foundation Cellerator P/S to Novo Nordisk Foundation Cellerator A/S.
Contact info changed: new email: [email protected], new website: www.cellerator.dk (June 29, 2026).
Novo Nordisk Foundation Cellerator A/S has published its annual report for 2025. Gross profit came to DKK 3,903,000, and the net result was DKK -13,054,000.
Contact info changed: new email: [email protected], new website: www.cellerator.dk (March 31, 2026).
As of December 23, 2025, Trine Haastrup has joined the board of directors of Novo Nordisk Foundation Cellerator A/S.
As of December 23, 2025, Søren Nedergaard has left the board of directors of Novo Nordisk Foundation Cellerator A/S.
As of December 23, 2025, Erika Johanna Söderberg Johnsson has left the board of directors of Novo Nordisk Foundation Cellerator A/S.
Novo Nordisk Foundation Cellerator A/S has published its interim report for the period November 23, 2023 to December 31, 2024.
As of November 23, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Novo Nordisk Foundation Cellerator A/S.
As of November 23, 2023, Pelle Kristoffer Munk-Poulsen has joined the board of directors of Novo Nordisk Foundation Cellerator A/S.
As of November 23, 2023, Mads Krogsgaard Thomsen has joined the board of directors of Novo Nordisk Foundation Cellerator A/S.
As of November 23, 2023, Søren Nedergaard has joined the board of directors of Novo Nordisk Foundation Cellerator A/S.
As of November 23, 2023, Erika Johanna Söderberg Johnsson has joined the board of directors of Novo Nordisk Foundation Cellerator A/S.
As of November 23, 2023, Thomas Hassing Ronøe Carlsen is registered as director of Novo Nordisk Foundation Cellerator A/S.
As of November 23, 2023, NOVO NORDISK FONDEN is registered as an owner of Novo Nordisk Foundation Cellerator A/S with an ownership share of 100%.
Novo Nordisk Foundation Cellerator A/S was founded on November 23, 2023.
Companies in the same industry and area
CVR 57821159
CVR 37300233
CVR 41933690
CVR 15994142
CVR 41269774